Animal Model Market
Animal Model Market Analysis by Species (Rat Models, Mice Models, Guinea Pig Models, Rabbit Models, Monkey Models), by Application (Basic & Applied Research, Drug Discovery/Development), by End User, by Region - Global Forecast 2022 to 2032
Analysis of Animal Model market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Animal Model Market Outlook (2022 to 2032)
The animal model market is expected to be worth US$ 1.7 Billion in 2022, rising to US$ 2.9 Billion by 2032, documenting a CAGR of 5.5% from 2022 to 2032.
| Report Attributes | Details |
|---|---|
|
Anticipated Base Year Value (2021) |
US$ 1.6 Billion |
|
Expected Market Value (2022) |
US$ 1.7 Billion |
|
Projected Forecast Value (2032) |
US$ 2.9 Billion |
|
Global Growth Rate (2022-2032) |
5.5% CAGR |
|
Growth Rate of the U.S (2022-2032) |
5.8% CAGR |
|
Expected Market Value of China (2032) |
US$ 0.7 Billion |
|
Key Animal Model Service Providers |
Genoway SA; Eurofins Scientific SE; Crown Bioscience Inc.; Envigo CRS SA; Transposagen Biopharmaceuticals, Inc.; Trans Genic Inc.; The Jackson Laboratory; Horizon Discovery Group Plc.; Charles River Laboratories International Inc. |
Over the evaluation period of 2022 to 2032, demand for animal models in academic and research institutions is expected to rise at a CAGR of 6%. As of 2021, the industry was valued at US$ 1.6 Billion, and is expected to grow at a Y-o-Y expansion rate of 6.2% in 2022.
The rising number of clinical trials and increased spending on this research are the primary drivers of market expansion. According to European Medicine Agency statistics, there are now (2020) 37,293 clinical studies registered in Europe. Furthermore, according to the World Health Organization, the number of registered trials in South East Asia was approximately 92% in 2019 and around 66% in the Eastern Mediterranean area.
Animal models are regarded as a critical tool in clinical research investigations for predicting human data. It aids in identifying drug pharmacodynamics and pharmacokinectics. Furthermore, the European Federation of Pharmaceutical Industries and Associations said that the total revenues of the pharmaceutical business globally were around US$ 852 Million.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Animal Model Market Revenue Analysis 2015 to 2021 vs. Future Outlook 2022 to 2032
From 2015 to 2021, the worldwide animal model market grew at a 4.8% CAGR. Animals and humans have a similar biological and physiological structure. Animals have a shorter life cycle, yet they share a high level of genetic similarities. In comparison to humans, controlling the animal habitat is straightforward and uncomplicated.
Animal models are increasingly being employed in biomedical research to aid in the development of innovative treatment strategies for a wide range of ailments. Using animal models allows for a better knowledge of various diseases as well as the efficiency of medications in treating them. As a result of these circumstances, the need for animal models in the healthcare sector has increased significantly.
Alternatives include cell cultures, tissue cultures, and computer models; but, due to the intricacy of biological systems, animal models are preferable. This makes animal models an even better alternative for biological study. Iterative development of animal models that are more predictive of effectiveness is required.
Researchers are using innovative experimental methodologies to clarify the biology of certain illnesses in order to create new and efficient animal model systems. Researchers are recommended to test medications in model organisms as well as mice strains with varied genetic origins while developing novel treatments for complicated disorders.
The market is growing due to the increasing use of animal models in drug development and the rising need for efficient animal models. Based on the aforementioned reasons, the global animal model market is expected to grow at a CAGR of 5.5% between 2022 and 2032.
Prominent Animal Model Industry Growth Drivers
Innovative Therapies to Surge up Market Growth
The increasing use of animal species to develop various innovative therapies is expected to fuel the growth of the animal model market. Furthermore, the growing need for new treatments to meet the enormous unmet need is expected to be a major driver driving demand. The increasing global incidence of genetic diseases, as well as the growing research area, is expected to be the market's significant growth factors.
In addition, the use of animal models in many investigations of illness and human physiology is a major driver driving market expansion. Moreover, the increased pace of preclinical research for therapeutic approvals, as well as significant investments in R&D by prominent pharmaceutical firms are key drivers driving market expansion.
Animal Models will be required for Vaccine Testing and Development Deployment
Animal models are heavily used in the development of human vaccinations. Several regulatory agencies need innovative vaccine candidates to undergo preclinical testing in animal models before becoming eligible for clinical trials in human subjects.
With the use of computational biology and bioinformatics approaches for creating innovative vaccine candidates, significant progress in animal reduction and replacement has been observed in recent years. Despite this, the main objective for using a vaccination is to assist the immune system in identifying infections and eliciting a response.
The growing demand for vaccine testing and development is paving the way for animal model demand, propelling market expansion to new heights. Furthermore, animal models are often employed in biomedical research to develop novel treatment strategies for illnesses. The goal of gaining a greater knowledge of a condition, which also aids in the faster comprehension of therapeutic efficacy.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Key Challenges Prevalent in the Global Animal Model Market
Stringent Laws and Standards Regarding the Use of Animal Models may Impede Growth Prospects
Strict restrictions and criteria governing the use of animal models in research studies may have a detrimental influence on the growth of the animal model industry. In recent years, tight legislation and standards for animal protection and welfare have resulted in limited research techniques and restrictions on the use of animals for various scientific objectives in some countries.
Members of the European Parliament asked that the European Union develop an action plan to stop the use of animals in research and testing by 2021. Furthermore, in response to growing concern about the use of animals in cosmetic testing, a number of nations have taken steps to prohibit the use of animals in cosmetic industries.
Country-wise Analysis
What is the Potential of the US Animal Model Market?
Increasing Clinical Trials widening Growth Opportunities
According to Fact.MR, development in experimental services by biotech and pharmaceutical corporations via drug discovery, an increase in CROs' use of animal models, and an increasing focus on tailored pharmaceuticals, the United States is anticipated to be a leading country in the animal model market.
According to clinical trials.gov, almost 293,321 studies were registered at the start of the year, with around 32,523 studies registered at the conclusion of the year in 2019. Furthermore, according to the Pharmaceutical Research and Manufacturers of America, biopharmaceutical companies in the United States spent around US$ 79.6 billion on R&D in 2018.
As a consequence of the increasing number of clinical trials and huge investments in these studies, the pharmaceutical analytical testing market in the United States is expected to rise at a stellar CAGR OF 5.8%
What is the Animal Model Market Scenario in China?
Availability of Sophisticated Healthcare Systems Fueling the Market Growth
The Chinese market has a significant value share of the global market and is expected to maintain its dominance over the forecast period due to an increase in the number of programmes and rising government spending on overall R&D of pharmaceuticals using animal models, as well as the implications of mouse clinical trials (MCTs) for more accurately estimating outcomes.
Moreover, the market is predicted to grow as a result of continuing developments in animal models, the availability of sophisticated healthcare systems, and a significant increase in demand for advanced healthcare facilities.
Furthermore, animal model demand is expected to grow as major manufacturers focus on expanding their regional presence in order to achieve a significant market share. Owing to these factors, the Chinese market for animal models is anticipated to grow at a CAGR of 5.7% during the forecast period.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Country-wise Forecast CAGRs in the Animal Model Market
| Countries | Details |
|---|---|
| U.S | 5.8% |
| U.K | 5% |
| China | 5.7% |
| Japan | 4.5% |
| South Korea | 4.6% |
Category-wise Insights
Which Species is most likely to Boost Animal Model Activities?
Rat-Based Animal Models to be Top Growth Driver in the Coming Years
According to Fact.MR, revenue from rat-based animal models is expected to account for more than 40% of the market share by 2032. Revenue from the use of rats in animal models is expected to grow at the fastest rate through 2032.
Growing use of rat models to investigate a wide range of complex disorders, increased demand for rat models in biomedical research to better understand contemporary health concerns, and advances in gene-editing techniques, are all driving market growth.
Furthermore, greater use of personalized medicine, continuous government support in the form of funding and subsidies, and increased use of the rat model in drug research and discovery will further fuel prospects.
Which End User is most likely to Drive Demand for Animal Model Systems?
Deployment to be Maximum across Academic and Research Institutions
Academic and research institutions are expected to continue to be the fastest-growing end consumers of animal models. Academic and research institutions control more than half of the animal model business. Academic and research institutions are anticipated to grow at a CAGR of 6% over the assessment period.
The government is increasingly intervening in academic and research institutions to set uniform standards for animal models. The importance of animal research in advancing healthcare and medical science has been widely established, garnering support from researchers. Rapid advances in innovative technology have made animal models simple and useful.
Significant illness incidence rates, as well as adverse therapeutic effects, have prompted the use of animal models to ensure human safety. Furthermore, increased government participation in research institutes for the creation of standard protocols connected with animal models would fuel market growth.
Animal models are used in fundamental research, such as discovering novel therapeutic ways to treat human diseases, drug discovery, which involves target identification and validation, toxicological drug screening, lead optimization and safety screening, and preclinical drug safety and efficacy assessments.
Competitive Landscape
To expand their customer base and strengthen their industrial position, key animal model system suppliers are working on strategic acquisitions, mergers, collaborations, and partnerships. Recent investments by big corporations have offered opportunities for the sector to grow internationally. Some key developments are as follows:
- In April 2022, Taconic Biosciences and Biomodels collaborated to initiate the Taconic-Biomodels Microbiome Initiative (TBMI), providing investigators with seamless access to complete germ-free and gnotobiotic microbiome study solutions, from design to data. The solutions helps eliminate hurdles which have long limited microbiome research by combining access to relevant disease models, germ-free animal production, and downstream in-vivo research design, execution, and analytics.
- In September 2021, Inotiv Inc. and Envigo announced an agreement wherein the former has agreed to purchase the latter. With this acquisition, both companies will be able to better access products and services for the entirety of discovery and non-clinical development within one organization.
Key Segments Covered in the Animal Model Industry Report
-
Animal Model Market by Species :
- Rat Models
- Mice Models
- Guinea Pig Models
- Rabbit Models
- Monkey Models
- Dog Models
- Pig Models
- Cat Models
- Other Animal Species Models
-
Animal Model by Application :
- Animal Models for Basic & Applied Research
- Animal Models for Drug Discovery/Development
-
Animal Model by End User :
- Academic & Research Institutions
- Pharmaceutical Companies
- Biotechnology Companies
- Contract Research Organizations (Cros)
- Other End Users
-
Animal Model by Region :
- North America Animal Model Market
- Latin America Animal Model Market
- Europe Animal Model Market
- South Korea Animal Model Market
- APAC Animal Model Market
- Middle East & Africa Animal Model Market
Table of Content
- 1. Global Economic Outlook
- 2. Executive Summary
- 3. Overview
- 4. Global Market Analysis and Forecast 2015 to 2032
- 4.1. Global Market Size and Forecast By Species, 2015 to 2032
- 4.1.1. Rats
- 4.1.2. Mice
- 4.1.3. Guinea Pig
- 4.1.4. Rabbits
- 4.1.5. Monkeys
- 4.1.6. Dogs
- 4.1.7. Pigs
- 4.1.8. Cats
- 4.1.9. Other
- 4.2. Global Market Size and Forecast By End User, 2015 to 2032
- 4.2.1. Academic & Research Institutions
- 4.2.2. Pharmaceutical Companies
- 4.2.3. BioCompanies
- 4.2.4. Contract Research Organizations (CROs)
- 4.2.5. Other End Users
- 4.3. Global Market Size and Forecast By Application, 2015 to 2032
- 4.3.1. Basic and Applied Research
- 4.3.2. Drug Discovery/Development
- 4.4. Global Market Size and Forecast By Region, 2015 to 2032
- 4.4.1. North America
- 4.4.2. Latin America
- 4.4.3. Europe
- 4.4.4. South Korea
- 4.4.5. APAC
- 4.4.6. Middle East & Africa
- 4.1. Global Market Size and Forecast By Species, 2015 to 2032
- 5. North America Market Size and Forecast, 2015 to 2032
- 6. Latin America Market Size and Forecast, 2015 to 2032
- 7. Europe Market Size and Forecast, 2015 to 2032
- 8. South Korea Market Size and Forecast, 2015 to 2032
- 9. APAC Market Size and Forecast, 2015 to 2032
- 10. MEA Market Size and Forecast, 2015 to 2032
- 11. Global Market Company Share, Competition Landscape and Company Profiles
- 11.1. Horizon Discovery Group plc
- 11.2. The Jackson Laboratory
- 11.3. Trans Genic Inc.
- 11.4. Taconic Biosciences, Inc.
- 11.5. Genoway SA
- 11.6. Eurofins Scientific SE
- 11.7. Crown Bioscience, Inc.
- 11.8. Envigo CRS SA
- 11.9. Transposagen Biopharmaceuticals, Inc.
- 12. Research Methodology
- 13. Secondary and Primary Sources
- 14. Assumptions and Acronyms
- 15. Disclaimer
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
TABLE 01: Global Market Value (US$ Mn), 2015 to 2021 Source: FMI Analysis, 2021
TABLE 02: Global Market Value (US$ Mn), 2022 to 2032
TABLE 03: Global Market Value (US$ Mn) and Y-o-Y, 2022 to 2032
TABLE 04: Global Rats Segment Value (US$ Mn), By Region 2015 to 2021
TABLE 05: Global Rats Segment Value (US$ Mn), By Region 2022 to 2032
TABLE 06: Global Rats Segment Market Share, By Region 2015 to 2021
TABLE 07: Global Rats Segment Market Share, By Region 2022 to 2032
TABLE 08: Global Rats Segment Y-o-Y, By Region 2022 to 2032
TABLE 09: Global Mice Segment Value (US$ Mn), By Region 2015 to 2021
TABLE 10: Global Mice Segment Value (US$ Mn), By Region 2022 to 2032
TABLE 11: Global Mice Segment Market Share, By Region 2015 to 2021
TABLE 12: Global Mice Segment Market Share, By Region 2022 to 2032
TABLE 13: Global Mice Segment Y-o-Y, By Region 2022 to 2032
TABLE 14: Global Guinea Pig Segment Value (US$ Mn), By Region 2015 to 2021
TABLE 15: Global Guinea Pig Segment Value (US$ Mn), By Region 2022 to 2032
TABLE 16: Global Guinea Pig Segment Market Share, By Region 2015 to 2021
TABLE 17: Global Guinea Pig Segment Market Share, By Region 2022 to 2032
TABLE 18: Global Guinea Pig Segment Y-o-Y, By Region 2022 to 2032
TABLE 19: Global Rabbits Segment Value (US$ Mn), By Region 2015 to 2021
TABLE 20: Global Rabbits Segment Value (US$ Mn), By Region 2022 to 2032
TABLE 21: Global Rabbits Segment Market Share, By Region 2015 to 2021
TABLE 22: Global Rabbits Segment Market Share, By Region 2022 to 2032
TABLE 23: Global Rabbits Segment Y-o-Y, By Region 2022 to 2032
TABLE 24: Global Monkeys Segment Value (US$ Mn), By Region 2015 to 2021
TABLE 25: Global Monkeys Segment Value (US$ Mn), By Region 2022 to 2032
TABLE 26: Global Monkeys Segment Market Share, By Region 2015 to 2021
TABLE 27: Global Monkeys Segment Market Share, By Region 2022 to 2032
TABLE 28: Global Monkeys Segment Y-o-Y, By Region 2022 to 2032
TABLE 29: Global Dogs Segment Value (US$ Mn), By Region 2015 to 2021
TABLE 30: Global Dogs Segment Value (US$ Mn), By Region 2022 to 2032
TABLE 31: Global Dogs Segment Market Share, By Region 2015 to 2021
TABLE 32: Global Dogs Segment Market Share, By Region 2022 to 2032
TABLE 33: Global Dogs Segment Y-o-Y, By Region 2022 to 2032
TABLE 34: Global Pigs Segment Value (US$ Mn), By Region 2015 to 2021
TABLE 35: Global Pigs Segment Value (US$ Mn), By Region 2022 to 2032
TABLE 36: Global Pigs Segment Market Share, By Region 2015 to 2021
TABLE 37: Global Pigs Segment Market Share, By Region 2022 to 2032
TABLE 38: Global Pigs Segment Y-o-Y, By Region 2022 to 2032
TABLE 39: Global Cats Segment Value (US$ Mn), By Region 2015 to 2021
TABLE 40: Global Cats Segment Value (US$ Mn), By Region 2022 to 2032
TABLE 41: Global Cats Segment Market Share, By Region 2015 to 2021
TABLE 42: Global Cats Segment Market Share, By Region 2022 to 2032
TABLE 43: Global Cats Segment Y-o-Y, By Region 2022 to 2032
TABLE 44: Global Other Species Segment Value (US$ Mn), By Region 2015 to 2021
TABLE 45: Global Other Species Segment Value (US$ Mn), By Region 2022 to 2032
TABLE 46: Global Other Species Segment Market Share, By Region 2015 to 2021
TABLE 47: Global Other Species Segment Market Share, By Region 2022 to 2032
TABLE 48: Global Other Species Segment Y-o-Y, By Region 2022 to 2032
TABLE 49: Global Academic & Research Institutions Segment Value (US$ Mn), By Region 2015 to 2021
TABLE 50: Global Academic & Research Institutions Segment Value (US$ Mn), By Region 2022 to 2032
TABLE 51: Global Academic & Research Institutions Segment Market Share, By Region 2015 to 2021
TABLE 52: Global Academic & Research Institutions Segment Market Share, By Region 2022 to 2032
TABLE 53: Global Academic & Research Institutions Segment Y-o-Y, By Region 2022 to 2032
TABLE 54: Global Pharmaceutical Companies Segment Value (US$ Mn), By Region 2015 to 2021
TABLE 55: Global Pharmaceutical Companies Segment Value (US$ Mn), By Region 2022 to 2032
TABLE 56: Global Pharmaceutical Companies Segment Market Share, By Region 2015 to 2021
TABLE 57: Global Pharmaceutical Companies Segment Market Share, By Region 2022 to 2032
TABLE 58: Global Pharmaceutical Companies Segment Y-o-Y, By Region 2022 to 2032
TABLE 59: Global Biotechnology Companies Segment Value (US$ Mn), By Region 2015 to 2021
TABLE 60: Global Biotechnology Companies Segment Value (US$ Mn), By Region 2022 to 2032
TABLE 61: Global Biotechnology Companies Segment Market Share, By Region 2015 to 2021
TABLE 62: Global Biotechnology Companies Segment Market Share, By Region 2022 to 2032
TABLE 63: Global Biotechnology Companies Segment Y-o-Y, By Region 2022 to 2032
TABLE 64: Global Contract Research Organizations (CROs) Segment Value (US$ Mn), By Region 2015 to 2021
TABLE 65: Global Contract Research Organizations (CROs) Segment Value (US$ Mn), By Region 2022 to 2032
TABLE 66: Global Contract Research Organizations (CROs) Segment Market Share, By Region 2015 to 2021
TABLE 67: Global Contract Research Organizations (CROs) Segment Market Share, By Region 2022 to 2032
TABLE 68: Global Contract Research Organizations (CROs) Segment Y-o-Y, By Region 2022 to 2032
TABLE 69: Global Other End Users Segment Value (US$ Mn), By Region 2015 to 2021
TABLE 70: Global Other End Users Segment Value (US$ Mn), By Region 2022 to 2032
TABLE 71: Global Other End Users Segment Market Share, By Region 2015 to 2021
TABLE 72: Global Other End Users Segment Market Share, By Region 2022 to 2032
TABLE 73: Global Other End Users Segment Y-o-Y, By Region 2022 to 2032
TABLE 74: Global Basic and Applied Research Segment Value (US$ Mn), By Region 2015 to 2021
TABLE 75: Global Basic and Applied Research Segment Value (US$ Mn), By Region 2022 to 2032
TABLE 76: Global Basic and Applied Research Segment Market Share, By Region 2015 to 2021
TABLE 77: Global Basic and Applied Research Segment Market Share, By Region 2022 to 2032
TABLE 78: Global Basic and Applied Research Segment Y-o-Y, By Region 2022 to 2032
TABLE 79: Global Drug Discovery/Development Segment Value (US$ Mn), By Region 2015 to 2021
TABLE 80: Global Drug Discovery/Development Segment Value (US$ Mn), By Region 2022 to 2032
TABLE 81: Global Drug Discovery/Development Segment Market Share, By Region 2015 to 2021
TABLE 82: Global Drug Discovery/Development Segment Market Share, By Region 2022 to 2032
TABLE 83: Global Drug Discovery/Development Segment Y-o-Y, By Region 2022 to 2032
TABLE 84: North America Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 85: North America Per Capita Health Expenditure (US$ PPP), by Country, 2015 to 2021
TABLE 86: North America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2015 to 2021
TABLE 87: North America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2015 to 2021
TABLE 88: North America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2015 to 2021
TABLE 89: North America Market Value (US$ Mn), By Country 2015 to 2021
TABLE 90: North America Market Value (US$ Mn), By Country 2022 to 2032
TABLE 91: North America Market Value (US$ Mn), By Species 2015 to 2021
TABLE 92: North America Market Value (US$ Mn), By Species 2022 to 2032
TABLE 93: North America Market Value (US$ Mn), By End User 2015 to 2021
TABLE 94: North America Market Value (US$ Mn), By End User 2022 to 2032
TABLE 95: North America Market Value (US$ Mn), By Application 2015 to 2021
TABLE 96: North America Market Value (US$ Mn), By Application 2022 to 2032
TABLE 97: Latin America Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 98: Latin America Per Capita Health Expenditure (US$ PPP), by Country, 2015 to 2021
TABLE 99: Latin America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2015 to 2021
TABLE 100: Latin America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2015 to 2021
TABLE 101: Latin America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2015 to 2021
TABLE 102: Latin America Market Value (US$ Mn), By Country 2015 to 2021
TABLE 103: Latin America Market Value (US$ Mn), By Country 2022 to 2032
TABLE 104: Latin America Market Value (US$ Mn), By Species 2015 to 2021
TABLE 105: Latin America Market Value (US$ Mn), By Species 2022 to 2032
TABLE 106: Latin America Market Value (US$ Mn), By End User 2015 to 2021
TABLE 107: Latin America Market Value (US$ Mn), By End User 2022 to 2032
TABLE 108: Latin America Market Value (US$ Mn), By Application 2015 to 2021
TABLE 109: Latin America Market Value (US$ Mn), By Application 2022 to 2032
TABLE 110: Europe Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 111: Europe Per Capita Health Expenditure (US$ PPP), by Country, 2015 to 2021
TABLE 112: Europe Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2015 to 2021
TABLE 113: Europe Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2015 to 2021
TABLE 114: Europe Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2015 to 2021
TABLE 115: Europe Market Value (US$ Mn), By Country 2015 to 2021
TABLE 116: Europe Market Value (US$ Mn), By Country 2022 to 2032
TABLE 117: Europe Market Value (US$ Mn), By Species 2015 to 2021
TABLE 118: Europe Market Value (US$ Mn), By Species 2022 to 2032
TABLE 119: Europe Market Value (US$ Mn), By End User 2015 to 2021
TABLE 120: Europe Market Value (US$ Mn), By End User 2022 to 2032
TABLE 121: Europe Market Value (US$ Mn), By Application 2015 to 2021
TABLE 122: Europe Market Value (US$ Mn), By Application 2022 to 2032
TABLE 123: South Korea Market Value (US$ Mn), By Country 2015 to 2021
TABLE 124: South Korea Market Value (US$ Mn), By Country 2022 to 2032
TABLE 125: South Korea Market Value (US$ Mn), By Species 2015 to 2021
TABLE 126: South Korea Market Value (US$ Mn), By Species 2022 to 2032
TABLE 127: South Korea Market Value (US$ Mn), By End User 2015 to 2021
TABLE 128: South Korea Market Value (US$ Mn), By End User 2022 to 2032
TABLE 129: South Korea Market Value (US$ Mn), By Application 2015 to 2021
TABLE 130: South Korea Market Value (US$ Mn), By Application 2022 to 2032
TABLE 131: APAC Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 132: APAC Per Capita Health Expenditure (US$ PPP), by Country, 2015 to 2021
TABLE 133: APAC Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2015 to 2021
TABLE 134: APAC Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2015 to 2021
TABLE 135: APAC Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2015 to 2021
TABLE 136: APAC Market Value (US$ Mn), By Country 2015 to 2021
TABLE 137: APAC Market Value (US$ Mn), By Country 2022 to 2032
TABLE 138: APAC Market Value (US$ Mn), By Species 2015 to 2021
TABLE 139: APAC Market Value (US$ Mn), By Species 2022 to 2032
TABLE 140: APAC Market Value (US$ Mn), By End User 2015 to 2021
TABLE 141: APAC Market Value (US$ Mn), By End User 2022 to 2032
TABLE 142: APAC Market Value (US$ Mn), By Application 2015 to 2021
TABLE 143: APAC Market Value (US$ Mn), By Application 2022 to 2032
TABLE 144: MEA Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 145: MEA Per Capita Health Expenditure (US$ PPP), by Country, 2015 to 2021
TABLE 146: MEA Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2015 to 2021
TABLE 147: MEA Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2015 to 2021
TABLE 148: MEA Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2015 to 2021
TABLE 149: MEA Market Value (US$ Mn), By Country 2015 to 2021
TABLE 150: MEA Market Value (US$ Mn), By Country 2022 to 2032
TABLE 151: MEA Market Value (US$ Mn), By Species 2015 to 2021
TABLE 152: MEA Market Value (US$ Mn), By Species 2022 to 2032
TABLE 153: MEA Market Value (US$ Mn), By End User 2015 to 2021
TABLE 154: MEA Market Value (US$ Mn), By End User 2022 to 2032
TABLE 155: MEA Market Value (US$ Mn), By Application 2015 to 2021
TABLE 156: MEA Market Value (US$ Mn), By Application 2022 to 2032
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
FIG. 01: Global Market Value (US$ Mn), 2015 to 2021
FIG. 02: Global Market Value (US$ Mn) Forecast, 2022 to 2032
FIG. 03: Global Market Value (US$ Mn) and Y-o-Y, 2022 to 2032
FIG. 04: Global Rats Segment Market Value (US$ Mn) By Region, 2015 to 2021
FIG. 05: Global Rats Segment Market Value (US$ Mn) By Region, 2022 to 2032
FIG. 06: Global Rats Segment Y-o-Y Growth Rate, By Region, 2022 to 2032
FIG. 07: Global Mice Segment Market Value (US$ Mn) By Region, 2015 to 2021
FIG. 08: Global Mice Segment Market Value (US$ Mn) By Region, 2022 to 2032
FIG. 09: Global Mice Segment Y-o-Y Growth Rate, By Region, 2022 to 2032
FIG. 10: Global Guinea Pig Segment Market Value (US$ Mn) By Region, 2015 to 2021
FIG. 11: Global Guinea Pig Segment Market Value (US$ Mn) By Region, 2022 to 2032
FIG. 12: Global Guinea Pig Segment Y-o-Y Growth Rate, By Region, 2022 to 2032
FIG. 13: Global Rabbits Segment Market Value (US$ Mn) By Region, 2015 to 2021
FIG. 14: Global Rabbits Segment Market Value (US$ Mn) By Region, 2022 to 2032
FIG. 15: Global Rabbits Segment Y-o-Y Growth Rate, By Region, 2022 to 2032
FIG. 16: Global Monkeys Segment Market Value (US$ Mn) By Region, 2015 to 2021
FIG. 17: Global Monkeys Segment Market Value (US$ Mn) By Region, 2022 to 2032
FIG. 18: Global Monkeys Segment Y-o-Y Growth Rate, By Region, 2022 to 2032
FIG. 19: Global Dogs Segment Market Value (US$ Mn) By Region, 2015 to 2021
FIG. 20: Global Dogs Segment Market Value (US$ Mn) By Region, 2022 to 2032
FIG. 21: Global Dogs Segment Y-o-Y Growth Rate, By Region, 2022 to 2032
FIG. 22: Global Pigs Segment Market Value (US$ Mn) By Region, 2015 to 2021
FIG. 23: Global Pigs Segment Market Value (US$ Mn) By Region, 2022 to 2032
FIG. 24: Global Pigs Segment Y-o-Y Growth Rate, By Region, 2022 to 2032
FIG. 25: Global Cats Segment Market Value (US$ Mn) By Region, 2015 to 2021
FIG. 26: Global Cats Segment Market Value (US$ Mn) By Region, 2022 to 2032
FIG. 27: Global Cats Segment Y-o-Y Growth Rate, By Region, 2022 to 2032
FIG. 28: Global Other Species Segment Market Value (US$ Mn) By Region, 2015 to 2021
FIG. 29: Global Other Species Segment Market Value (US$ Mn) By Region, 2022 to 2032
FIG. 30: Global Other Species Segment Y-o-Y Growth Rate, By Region, 2022 to 2032
FIG. 31: Global Academic & Research Institutions Segment Market Value (US$ Mn) By Region, 2015 to 2021
FIG. 32: Global Academic & Research Institutions Segment Market Value (US$ Mn) By Region, 2022 to 2032
FIG. 33: Global Academic & Research Institutions Segment Y-o-Y Growth Rate, By Region, 2022 to 2032
FIG. 34: Global Pharmaceutical Companies Segment Market Value (US$ Mn) By Region, 2015 to 2021
FIG. 35: Global Pharmaceutical Companies Segment Market Value (US$ Mn) By Region, 2022 to 2032
FIG. 36: Global Pharmaceutical Companies Segment Y-o-Y Growth Rate, By Region, 2022 to 2032
FIG. 37: Global Biotechnology Companies Segment Market Value (US$ Mn) By Region, 2015 to 2021
FIG. 38: Global Biotechnology Companies Segment Market Value (US$ Mn) By Region, 2022 to 2032
FIG. 39: Global Biotechnology Companies Segment Y-o-Y Growth Rate, By Region, 2022 to 2032
FIG. 40: Global Contract Research Organizations (CROs) Segment Market Value (US$ Mn) By Region, 2015 to 2021
FIG. 41: Global Contract Research Organizations (CROs) Segment Market Value (US$ Mn) By Region, 2022 to 2032
FIG. 42: Global Contract Research Organizations (CROs) Segment Y-o-Y Growth Rate, By Region, 2022 to 2032
FIG. 43: Global Other End Users Segment Market Value (US$ Mn) By Region, 2015 to 2021
FIG. 44: Global Other End Users Segment Market Value (US$ Mn) By Region, 2022 to 2032
FIG. 45: Global Other End Users Segment Y-o-Y Growth Rate, By Region, 2022 to 2032
FIG. 46: Global Basic and Applied Research Segment Market Value (US$ Mn) By Region, 2015 to 2021
FIG. 47: Global Basic and Applied Research Segment Market Value (US$ Mn) By Region, 2022 to 2032
FIG. 48: Global Basic and Applied Research Segment Y-o-Y Growth Rate, By Region, 2022 to 2032
FIG. 49: Global Drug Discovery/Development Segment Market Value (US$ Mn) By Region, 2015 to 2021
FIG. 50: Global Drug Discovery/Development Segment Market Value (US$ Mn) By Region, 2022 to 2032
FIG. 51: Global Drug Discovery/Development Segment Y-o-Y Growth Rate, By Region, 2022 to 2032
FIG. 52: North America Market Value (US$ Mn), By Country 2015 to 2021
FIG. 53: North America Market Value (US$ Mn), By Country 2022 to 2032
FIG. 54: North America Market Value (US$ Mn), By Species 2015 to 2021
FIG. 55: North America Market Value (US$ Mn), By Species 2022 to 2032
FIG. 56: North America Market Value (US$ Mn), By End User 2015 to 2021
FIG. 57: North America Market Value (US$ Mn), By End User 2022 to 2032
FIG. 58: North America Market Value (US$ Mn), By Application 2015 to 2021
FIG. 59: North America Market Value (US$ Mn), By Application 2022 to 2032
FIG. 60: Latin America Market Value (US$ Mn), By Country 2015 to 2021
FIG. 61: Latin America Market Value (US$ Mn), By Country 2022 to 2032
FIG. 62: Latin America Market Value (US$ Mn), By Species 2015 to 2021
FIG. 63: Latin America Market Value (US$ Mn), By Species 2022 to 2032
FIG. 64: Latin America Market Value (US$ Mn), By End User 2015 to 2021
FIG. 65: Latin America Market Value (US$ Mn), By End User 2022 to 2032
FIG. 66: Latin America Market Value (US$ Mn), By Application 2015 to 2021
FIG. 67: Latin America Market Value (US$ Mn), By Application 2022 to 2032
FIG. 68: Europe Market Value (US$ Mn), By Country 2015 to 2021
FIG. 69: Europe Market Value (US$ Mn), By Country 2022 to 2032
FIG. 70: Europe Market Value (US$ Mn), By Species 2015 to 2021
FIG. 71: Europe Market Value (US$ Mn), By Species 2022 to 2032
FIG. 72: Europe Market Value (US$ Mn), By End User 2015 to 2021
FIG. 73: Europe Market Value (US$ Mn), By End User 2022 to 2032
FIG. 74: Europe Market Value (US$ Mn), By Application 2015 to 2021
FIG. 75: Europe Market Value (US$ Mn), By Application 2022 to 2032
FIG. 76: South Korea Market Value (US$ Mn), By Country 2015 to 2021
FIG. 77: South Korea Market Value (US$ Mn), By Country 2022 to 2032
FIG. 78: South Korea Market Value (US$ Mn), By Species 2015 to 2021
FIG. 79: South Korea Market Value (US$ Mn), By Species 2022 to 2032
FIG. 80: South Korea Market Value (US$ Mn), By Application 2015 to 2021
FIG. 81: South Korea Market Value (US$ Mn), By End User 2022 to 2032
FIG. 82: South Korea Market Value (US$ Mn), By Application 2015 to 2021
FIG. 83: South Korea Market Value (US$ Mn), By Application 2022 to 2032
FIG. 84: APAC Market Value (US$ Mn), By Country 2015 to 2021
FIG. 85: APAC Market Value (US$ Mn), By Country 2022 to 2032
FIG. 86: APAC Market Value (US$ Mn), By Species 2015 to 2021
FIG. 87: APAC Market Value (US$ Mn), By Species 2022 to 2032
FIG. 88: APAC Market Value (US$ Mn), By End User 2015 to 2021
FIG. 89: APAC Market Value (US$ Mn), By End User 2022 to 2032
FIG. 90: APAC Market Value (US$ Mn), By Application 2015 to 2021
FIG. 91: APAC Market Value (US$ Mn), By Application 2022 to 2032
FIG. 92: MEA Market Value (US$ Mn), By Country 2015 to 2021
FIG. 93: MEA Market Value (US$ Mn), By Country 2022 to 2032
FIG. 94: MEA Market Value (US$ Mn), By Species 2015 to 2021
FIG. 95: MEA Market Value (US$ Mn), By Species 2022 to 2032
FIG. 96: MEA Market Value (US$ Mn), By End User 2015 to 2021
FIG. 97: MEA Market Value (US$ Mn), By End User 2022 to 2032
FIG. 98: MEA Market Value (US$ Mn), By Application 2015 to 2021
FIG. 99: MEA Market Value (US$ Mn), By Application 2022 to 2032
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What was the market worth for animal model as of 2021?
As of 2021, Fact.MR estimated the animal model market to have reached US$ 1.6 Billion
What is the expected worth of the animal model industry in 2022?
By 2022, Fact.MR expected demand for Animal Modesto reach US$ 1.7 Billion
At what CAGR did the animal model market flourish from 2015-2021?
From 2015-2021, the Animal Model market grew at a 4.8% value CAGR
What is the expected forecast CAGR for Animal Model from 2022-2032?
From 2022-2032, animal model demand is likely to surge at a 5.5% CAGR
At what value will the market for Animal Model close in 2032?
By 2032, the market for Animal Models likely to be valued at US$ 2.9 Billion
What is the expected market value for the U.S animal model market?
By 2032, Fact.MR expects the U.S market for animal models to reach US$ 900 Million
How opportunistic is the Chinese market for animal models?
China is expected to register a 5.7% CAGR with regard to the animal model industry
What is the expected growth rate for the Japanese market?
Japan is expected to document a CAGR worth 4.5% in the Animal Model market
Which species will account for the maximum animal model revenue?
According to Fact.MR, rat-based animal models are expected to account for more than 40% revenue
By end user, which category is likely to remain prominent until 2032?
Academic and research institutions are anticipated to grow at a CAGR of 6% over the assessment period.
Animal Model Market